Background {#Sec1}
==========

About 10% of new and relapse tuberculosis (TB) cases occur in children under 15 years of age; accounting for at least 1 million cases a year \[[@CR1]\]. Identifying and treating TB in children forms an essential part of TB control but detecting infection and diagnosing paediatric TB are challenging. Principally due to its paucibacillary nature, microbiological diagnosis of TB disease in children is insensitive. Hence, diagnosis is mainly based on clinical symptoms, which resemble those of other respiratory diseases \[[@CR2]\]. Screening for *Mycobacterium tuberculosis complex* (MTBC) infection is done by the widely implemented tuberculin skin test (TST) or the interferon gamma (IFN-γ) release assay (IGRA), both assessing the host's cell mediated immune response to tuberculous antigens \[[@CR3]\]. Both tests have their limitations \[[@CR4]\]. The TST --employing purified protein derivative (PPD) as antigen---has a low specificity due to cross reactivity with Bacillus Calmette-Guérin (BCG) vaccination and exposure to non-pathogenic environmental mycobacteria \[[@CR5]\]. The IGRA --employing antigens 6 kDa early secretory antigenic target (ESAT-6) and 10 kDa culture filtrate (CFP-10) (EC) as peptide pool or as fusion protein---is less sensitive for detection of *M. africanum* (*Maf*) infection compared to the classical *M. tuberculosis (Mtb)* sensu stricto strains infection \[[@CR6]\]; particularly important for countries like The Gambia where up to half of MTBC infections are caused by *Maf* strains \[[@CR7]\]. Both the TST and IGRA cannot distinguish between infection and TB disease or individuals with high risk of progressing towards TB disease \[[@CR8], [@CR9]\]. These separations are important, as patients need to receive timely and appropriate treatment.

Evaluating new antigens for stimulation assays might solve the issues with sensitivity and specificity for MTBC infection screening. Antigens of recent interest are Resuscitation promoting factors (Rpf); secreted bacterial proteins initially characterized by their capacity to resuscitate nonreplicating cells in vitro and in vivo through lysozyme and peptidoglycan hydrolase activities \[[@CR10]\]. Resuscitation promoting factors are specifically secreted by mycobacteria that shift from a dormant to their active replicating stage, in which they cause symptomatic disease \[[@CR11], [@CR12]\]. Five homologous Rpf genes (Rv0867c (RpfA); Rv1009 (RpfB); Rv1884c (RpfC); Rv2389c (RpfD); Rv2450c (RpfE)) have been identified in the genome of several mycobacteria, including *Mtb*, *Maf* and BCG \[[@CR12], [@CR13]\]. Resuscitation promoting factor A-, D- and E-specific IFN-γ responses in adults differ between infected and TB diseased individuals \[[@CR14], [@CR15]\]. Moreover, Huang et al found that the IFN-γ response to RpfA and D was associated with different levels of TB exposure and that it could possibly predict progression towards active disease in adults \[[@CR16]\].

To the best of our knowledge, Rpf-specific IFN-γ responses have not previously been evaluated in children and could potentially be employed to improve childhood TB screening and diagnostics. We assessed the ability of Rpf to detect MTBC infection and to discriminate infection from TB disease among household-exposed children in The Gambia.

Methods {#Sec2}
=======

Study population and ethics {#Sec3}
---------------------------

This study was approved by the MRC/Gambian government joint ethics committee. From January to December 2017, children aged below 15 years who were permanent household contacts of an adult smear-positive index TB case were recruited into the study. Written informed consent was obtained from the parents/guardians of the children prior to inclusion into the study.

Clinical examination {#Sec4}
--------------------

Symptom screening was performed with a standard questionnaire including cough, fatigue, haemoptysis, weight loss, fever, neck swelling, night sweats and wheezing. Participants were considered symptomatic if persistent unremitting cough of ≥2 weeks duration was reported, with at least one other symptom as described before \[[@CR17]\]. A TST was performed on all asymptomatic children, using the Mantoux method (2 tuberculin units, PPD RT23 *Statens Serum Institut*, Denmark), and induration size was read 48--72 h later. A skin induration of ≥10 mm measured transversely was considered TST positive (TST+), in line with WHO recommendations \[[@CR18]\]. To save the scarce and expensive PPD antigens for children that needed it most, children that were considered symptomatic did not receive a TST. All children that were either TST+ or symptomatic underwent detailed clinical evaluation in the MRC clinic, including HIV testing and a chest X-ray as described before \[[@CR17]\].

Sample collection {#Sec5}
-----------------

Sputum was collected from all participants that were symptomatic and/or had an abnormal chest X-ray, either spontaneously or induced in children who were unable to expectorate. Samples were used for sputum microscopy, MTB/RIF assay (Gene*Xpert, Cepheid*) and mycobacterial liquid culture in the *MGIT BACTEC* instrument (*Becton-Dickinson*). All culture positive samples were genotyped using the spoligotyping method. For each adult TB index case up to 3 TST- and 3 TST+ children living within their household were included in this study. Venous blood (5 mL) was collected in a heparinized tube and stimulated with antigens within 4 h of collection. The laboratory team was blinded to all clinical information of the participants.

Rpf antigens {#Sec6}
------------

Recombinant RpfA-E were kindly provided by Leiden University Medical Centre, The Netherlands and produced as previously described \[[@CR19]\]. The antigens were freeze-dried and shipped at room temperature. The same batch of antigens was used throughout the study.

Whole blood stimulation assay and IGRA {#Sec7}
--------------------------------------

Heparinized whole blood was stimulated on a U-bottom 96-well plate in duplicate with and without stimulant. According to blood volume available, the antigens included RpfA-E (final concentration 10 μg/mL) \[[@CR16]\], PPD (final concentration 10 μg/mL, RT23, *Statens Serum Institute*, Denmark), ESAT-6/CFP-10 (EC)-fusion protein (final concentration 10 μg/mL) \[[@CR3], [@CR20]--[@CR22]\], Phytohemagglutinin Antigen-L (PHA-L, final concentration 10 μg/mL, *Sigma Aldrich*, USA) in RPMI-1640 medium (complemented with Penicillin and Streptomycin, final concentration 100 U/mL Penicillin, 100 μg/mL Streptomycin, *Gibco Invitrogen*, USA) to a final volume of 100 μl/well. Plates were incubated for 18--22 h at 37 °C, 5% CO~2~, followed by harvesting and freezing the supernatants at − 20 °C. The IFN-γ concentration in the supernatants was quantified with enzyme-linked immunosorbent assay (ELISA) (in-house ELISA, performed as described before \[[@CR21]\]) and the optical density (OD) was read at 450 nm (*Softmax Pro* plate reader). Concentrations were calculated with a four-parameter curve fit (*Softmax Pro* software). The IGRA cut-off was set to 124.2 pg/mL, derived from the IFN-γ concentration mean of all unstimulated samples plus two times standard deviation \[[@CR21], [@CR23]\]. EC-specific IFN-γ levels above the cut-off were considered IGRA positive (IGRA+).

Definition of MTBC infection and TB disease {#Sec8}
-------------------------------------------

All participants that were IGRA+ were defined as "MTBC infected" and all IGRA negative (IGRA-) participants as "MTBC uninfected". "TB disease" was defined by mycobacterial confirmation and/or clinical diagnosis (i.e., suggestive appearance on chest radiograph, no response to empirical broad-spectrum antibiotics or favourable response to anti-tuberculous therapy), as described before \[[@CR21]\].

Data analysis {#Sec9}
-------------

Categorical data were reported as frequency and proportions. Medians and interquartile ranges (IQRs) were calculated for non-normally distributed continuous data. IFN-γ levels were corrected to antigen specific responses by subtracting the IFN-γ level in the unstimulated control (i.e.*,* baseline IFN-γ level). Continuous TST (in mm) and IGRA (in IFN-γ concentration) results were compared using Spearman's rank correlation. Binomial TST, IGRA and TB disease status results were compared with age (in years) using a Mann Whitney U-test and with sex using a two-tailed Fisher's test. For every antigen, ln (IFN-γ) (natural logarithm transformation) was compared between the different infection/disease groups with a binomial logistic regression model while correcting for age and sex. The log-transformation was done to minimise skewed distributions of IFN-y concentrations. Significance level was *p* \< 0.05. A Bonferroni correction was used to correct for multiple testing of 5 antigens of interest. *P*-values \< 0.01 were considered highly significant (0.05/5 = 0.01). Antigens that induced highly significant differences were further investigated: a Receiver Operating Characteristic (ROC) curve was produced for varying infection/disease classifications with the Rpf-specific IFN-γ values. The area under the curve (AUC) of the ROC plots was calculated and an ideal cut-off was chosen using the Youden Index \[[@CR24]\]. *R* version 3.2.3 was used for all analysis, specifically package *stats* for logistic regression analysis and package *ROCR* for ROC-curve analysis.

Results {#Sec10}
=======

Study participant demographics, TST screening and TB disease diagnosis {#Sec11}
----------------------------------------------------------------------

A total of 93 children all tested HIV-negative were included in this study with a median (IQR) age of 8.0 (4.7--10.9) years and 47 (50.5%) were female. Forty-three (43; 46.2%) children were symptomatic with a median (IQR) age of 9.7 (6.2--12.0). A BCG scar was present in 61 out of 66 (92.4%) assessed children. TB disease was diagnosed in 28 (30.1%) children (5 cases were bacteriologically confirmed TB all of the *M. tuberculosis* Euro-American lineage also called *Mtb*-lineage 4 and clinically diagnosed TB were 23 cases) (Fig. [1](#Fig1){ref-type="fig"}). The remaining 15 children were deemed to have other respiratory diseases. Fifty children (all asymptomatic) received the Mantoux test (tuberculin skin test; TST) and 26 (52.0%) were TST+. Fig. 1Flow diagram of all participants per screening category included in the study. TST: tuberculin skin test; IGRA: interferon gamma release assay; TB: tuberculosis; EC: ESAT-6/CFP-10 fusion protein

IGRA results and MTBC infection {#Sec12}
-------------------------------

To define MTBC infection status of the study participants, the EC-fusion protein IGRA result was taken as gold standard, with IFN-γ cut-off 124.2 pg/mL. Overall, EC-fusion protein induced a high IFN-γ response in all study participants (median (IQR) 275.5 (74.7--1435.0) pg/mL). Among the 65 children without TB disease (asymptomatic or symptomatic), 45 (70.3%) were IGRA+.

Comparison of TST and IGRA results, and age within the subgroups {#Sec13}
----------------------------------------------------------------

Among the 50 children who received a TST, 22 (44.0%) were TST + IGRA+, 12 (24.0%) were TST-IGRA- and 16 children had discordant results (Fig. [1](#Fig1){ref-type="fig"}). Tuberculin skin test and IGRA results (in mm skin induration and IFN-γ levels, respectively) were correlated (Spearman's ρ 0.4; *P* \< 0.001) \[see Additional file [1](#MOESM1){ref-type="media"}, Supplementary Figure 1\]. Tuberculin skin test+ children were older than TST- children (median (IQR) 7.5 (5.0--8.8) years versus 4.0 (3.0--7.3) years; *P* = 0.05) \[see Additional file [1](#MOESM1){ref-type="media"}, Supplementary Figure 2\]. There was a borderline age difference between IGRA+ (infected) and IGRA- (uninfected) children (median (IQR) 8.0 (5.0--10.0) years versus 4.5 (3.0--8.0) years; *P* = 0.06) \[see Additional file [1](#MOESM1){ref-type="media"}, Supplementary Figure 3\]. TB diseased children were significantly older than children without TB disease (irrespective of infection status) (median (IQR) 9.7 (6.0--12.2) years versus 7.0 (4.0--9.0) years, *P* = 0.02). There was no difference in age between children with bacteriologically confirmed and clinically diagnosed TB disease. We observed a trend of TB disease and infection in older children compared to younger children, which aligns with the slow progression to nature of MTBC infection. Resuscitation promoting factor-specific IFN-γ responses did not differ between children age below 5 years and above 5 years, and there was no correlation between Rpf-specific IFN-γ levels and age in years (data not shown).

IFN-γ response to RpfA-D in MTBC infected compared to uninfected children without TB disease {#Sec14}
--------------------------------------------------------------------------------------------

Whole blood stimulation with Rpf induced significantly higher IFN-γ responses in the infected (IGRA+) compared to the uninfected (IGRA-) children among those without TB disease. The medium (IQR) IFN-γ level of infected versus uninfected children was 34.6 (5.2--73.0) pg/mL versus 3.0 (0.0--11.1) pg/mL (*P* = 0.03) for RpfA, 77.4 (21.3--235.7) pg/mL versus 13.6 (0.0--31.6) pg/mL (*P* = 0.007) for RpfB, 45.0 (25.9--115.8) pg/mL versus 24.9 (0.0--30.4) pg/mL (*P* = 0.03) for RpfC, and 138.0 (67.5--340.5) pg/mL versus 49.3 (16.3--105.1) pg/mL (*P* = 0.004) for RpfD (see Fig. [2](#Fig2){ref-type="fig"}). Purified protein derivative induced a higher IFN-γ response in infected children (medium (IQR) 1078.9 (113.1--3937.8) pg/mL versus 92.7 (3.8--350.1) pg/mL, *P* = 0.01). Fig. 2IFN-γ response after ex vivo whole blood antigen stimulation. The first panel (**a**) "medium" depicts the results of the unstimulated assays, i.e., the background level. The other panels (**b**-**h**) represent the respective antigen-stimulated assays. Solid lines: median IFN- γ values per infection category. IFN-γ concentrations were corrected for the background signal (value of unstimulated IFN-γ level subtracted), except for the results in the first panel "medium". All values above 4000 were set to 4000 pg/mL. *P*-values below 0.05 indicated. P-values were derived from logistic regression models including possible confounders age and sex, after log-transformation of the IFN-γ variable. IGRA: IFN-γ release assay; EC: Esat-6/CFP-10; PPD: Purified protein derivative; Rpf: Resuscitation promoting factor

Performance of RpfB and D in an IGRA-based test for screening MTBC infection {#Sec15}
----------------------------------------------------------------------------

In our quest for a suitable alternative screening antigen, RpfB and D were found to induce the most differential IFN-γ response (*P* \< 0.01; Fig. [2](#Fig2){ref-type="fig"}). This result motivated our decision to further analyse their discriminatory capacity using ROC-curves. The area under the curves (AUC) were 0.77 and 0.74 for RpfB and RpfD, respectively (Fig. [3](#Fig3){ref-type="fig"}). Based on the Youden Index, a cut-off at 33.9 pg/mL for RpfB-specific IFN-γ levels was derived, leading to 73% (24/33) sensitivity and 92% (12/13) specificity (Fig. [3](#Fig3){ref-type="fig"}). Similarly, for RpfD, a cut-off of 67.0 pg/mL led to 77% (33/43) sensitivity and 72% (13/18) specificity (Fig. [3](#Fig3){ref-type="fig"}). For the TST, these figures were 65% (22/34) sensitivity and 75% (12/16) specificity (Fig. [1](#Fig1){ref-type="fig"}). Fig. 3ROC-curves for RpfB and RpfD in an IGRA-based screening for MTBC infection. IGRA+ participants were classified as infected and IGRA- participants were classified as uninfected. AUC's for RpfB and D are 0.77 and 0.74, respectively. Cut-off values for IFN-γ levels were based on the Youden Index. For RpfB, a cut-off at 33.9 pg/mL led to 73% sensitivity and 92% specificity. For RpfD, a cut-off of 67.0 pg/mL led to 77% sensitivity and 72% specificity. ROC: Receiver operating curve; Rpf: Resuscitation promoting factor; IGRA (interferon gamma release assay); AUC: area under the curve

In contrast, when using TST results as standard only the stimulations with EC-fusion protein and PPD induced a significantly different IFN-γ response between infected and uninfected groups (*P* = 0.004 and 0.003 respectively \[see Additional file [1](#MOESM1){ref-type="media"}, Supplementary Figure 4\]).

IFN-γ response to RpfB and D in MTBC infected compared to diseased children {#Sec16}
---------------------------------------------------------------------------

Since RpfB and D responses could discriminate between infected and uninfected children, we evaluated the diagnostic performance of TB disease. Resuscitation promoting factor B and D induced a significantly higher IFN-γ response in infected compared to TB diseased children (medium (IQR) 47.1 (7.1--129.8) pg/mL versus 9.1 (0.0--75.3) pg/mL, *P* = 0.02 and 91.1 (40.9--284.5) pg/mL versus 60.1 (11.0--114.2) pg/mL, *P* = 0.03) respectively (Fig. [2](#Fig2){ref-type="fig"}). EC-fusion protein induced higher IFN-γ responses in infected compared to TB diseased children (*P* = 0.0002), but no significant difference was obtained with PPD stimulation between these groups (Fig. [2](#Fig2){ref-type="fig"}). There was no significant difference in IFN-γ response between uninfected and TB diseased children for any of the Rpf antigens, EC or PPD (Fig. [2](#Fig2){ref-type="fig"}).

Background IFN-γ response in TB diseased children compared to children without TB disease {#Sec17}
-----------------------------------------------------------------------------------------

In general, TB diseased children had significantly higher background IFN-γ responses (whole blood stimulated with medium alone) compared to the other children without TB disease (irrespective of their infection status) (medium (IQR) 52.6 (42.0--78.4) pg/mL versus 18.6 (0.0--41.7) pg/mL, *P* = 0.0003) (Fig. [2](#Fig2){ref-type="fig"}). Using an ROC-curve, we further analysed the medium background response as a screening and/or diagnosis tool in our study setting. The AUC was 0.77, and at optimal cut-off 33.3 mg/mL (based on the Youden Index), sensitivity and specificity were 92.9 and 63.1%, respectively \[see Additional file [1](#MOESM1){ref-type="media"}, Supplementary Figure 5\].

Discussion {#Sec18}
==========

We found that Rpf-specific IFN-γ responses are associated with MTBC infection status in household-exposed children in The Gambia. This suggests that Rpf are attractive antigens to consider for childhood TB screening and diagnostics. Screening for infection and diagnosing TB disease represent core challenges in paediatric TB, particularly in low- and middle-income countries, where TB prevalence is high and other paediatric illnesses with TB-resembling symptoms are common. Given the worldwide shortage of PPD for tuberculin skin testing and its inherent lack of sensitivity and specificity \[[@CR25]\], it is essential to develop new methods for MTBC infection screening, particularly for the high-risk group of household-exposed children of infectious adult TB patients, as recommended by the WHO.

We stimulated children's venous blood samples in vitro with Rpf antigens and showed that RpfB and D induce lower IFN-γ responses in uninfected children compared to infected children. In our study population, RpfB and RpfD -based IGRAs identified infection with higher sensitivity than a TST. This is in line with previous studies in adults. In a multi-side study in adults including The Gambia, Sutherland et al showed that soluble IFN-γ responses after 7 days whole blood stimulation with RpfA and RpfE but not RpfB were higher in TST+ than TST- participants without TB disease \[[@CR14]\]. Similarly, Huang et al reported that RpfA and RpfD induced higher IFN-γ responses in "latent tuberculosis infected" (LTBI) household adult contacts compared to community exposed infected participants and healthy controls \[[@CR16]\]. Commandeur et al also found that RpfA and RpfD induced different immune responses in vitro in infected adults than in healthy controls \[[@CR26]\]. There are clear differences in the discriminatory capacity of the different Rpf proteins in the highlighted previous studies in adults. However, RpfA-induced responses consistently differ between infected and uninfected adults across multiple studies. An explanation for the absence of strong discriminatory RpfA-induced IFN-γ responses in our experiments could be given by the experimental set-up. Our study that focussed on exploring the possibility of integrating Rpf in TB screening, investigated a short-term stimulation of \~ 20 h, contrary to previous studies, which used several days stimulation and added costimulatory molecules such as CD28 and CD49d. In addition, the participants' younger age likely affected our observed results. Because of the age-dependent maturation of the immune system, children's IFN-γ production tends to be lower and the contribution of T-cells producing IFN-γ is thought to be less compared to adults \[[@CR4], [@CR27], [@CR28]\].

We additionally explored whether Rpf could discriminate between infected and TB diseased children. Resuscitation promoting factor B and D also induced a significantly higher IFN-γ response in infected children compared to TB diseased children. Similar results were previously observed in adults \[[@CR14], [@CR16], [@CR29]\]. In vitro*,* RpfA-, B-, D-, and E-specific IFN-γ producing CD4^+^ T-cells are less abundant in TB diseased patients compared to infected individuals \[[@CR29], [@CR30]\]. These observations support the hypothesis that a Rpf-specific IFN-γ response can discriminate infected individuals from TB diseased cases. In our study population, Rpf responses did not differ between those with TB disease and those without TB disease (irrespective of infection status), due to the similar Rpf response in children with TB disease compared to uninfected children. Thus, our study does not show discriminatory power of Rpf for TB disease per se, it only shows a difference between children with infection and TB disease. This difference further confirms the pattern of Rpf production during infection, which specifically increase as the bacteria transit from latency to active replication associated with progression to TB disease \[[@CR15], [@CR16], [@CR26]\]. With respect to the diagnosis of TB disease, Rpf may only be useful when the infection status of the patient is already ascertained. However, IFN-γ responses to Rpf might indicate whether individuals are at risk of developing TB disease in the near future following infection. Generally, the background IFN-γ production was significantly higher in TB diseased children compared to children without TB disease. The ROC-curve analysis at 33.3 pg/mL cut-off could have identified children with TB disease from children without TB disease with a sensitivity of 92.9%, but with a specificity of 63.1%. Of note, this cut-off is relatively low, in particular when compared to the median (IQR) background IFN-γ level of 23.3 (5.0--37.2) pg/mL. The higher IFN-γ background response in TB diseased children might reflect the disease exacerbation profile that is accompanied by non-specific inflammation and deserves further attention \[[@CR28], [@CR31]\].

Our study has some clear limitations regarding infection classification and the study population. We defined MTBC infection by a single test, i.e., IGRA with EC-fusion protein antigen. Although globally recognized as a standard for TB screening, the EC-based IGRA test is known to have lower sensitivity for *M. africanum* infection \[[@CR6]\] and in children below 5 years of age \[[@CR32]\]. In fact, our study of Rpf-induced IFN-γ production levels in IGRA+ and IGRA- children compares the immunogenicity of the EC and Rpf antigens. Therefore, our strict separation of infected versus uninfected children purely based on IGRA results should be considered with caution, as of course, there is no gold standard for MTBC infection. However, assuming that our IGRA results reflected the participants' infection status more accurately than the TST results that is confounded by BCG vaccination and exposure to environmental mycobacteria \[[@CR5]\], RpfB and D still hold promise for TB screening in children. Another limitation of our study is the modest sample size. This influenced the ROC-analyses, which in turn had impact on the cut-off for IFN-γ response. Another IFN-γ cut-off for RpfB and D would have resulted in a different specificity and sensitivity, which is why we strictly adhered to one method for selecting the ideal cut-off: the Youden Index. Furthermore, all participants were part of a childhood TB contact study, meaning that they had been exposed to an adult smear-positive index TB case. Consequently, no TB-unexposed negative controls were included. Future work should include a larger control group consisting of children with TB-like symptoms, but who do not have TB disease and with confirmed alternative diagnostics. This group of children is the biggest confounder of TB disease diagnosis in children based on clinical symptoms as these symptoms resemble that of other paediatric illnesses occurring in endemic regions \[[@CR33]\]. Moreover, our study did not include follow-up data on the progression from infection towards TB disease. Explicitly in the case of Rpf responses, this shift warrants further investigation, because these antigens could offer new possibilities for the prediction of progression to TB disease after exposure \[[@CR34]\]. Finally, we could not assess the effect of MTBC strains diversity on the Rpf-specific immune response because there were few bacilli culture positive sample. Future work would benefit from this additional piece of information, to paint a more complete picture of the possibilities and limitations of Rpf in the field of TB.

Conclusions {#Sec19}
===========

Our study shows that immune responses to RpfB and D can discriminate between household TB-exposed infected and uninfected children with higher accuracy than TST screening, with the EC-based IGRA taken as standard for MTBC infection. Additionally, both antigens induce a lower IFN-γ response in children with TB disease compared to infected children and thus warrant further investigation as screening and diagnostic antigens for childhood TB.
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**Additional file 1 Supplementary Figure 1.** TST induration size versus IGRA with EC-fusion protein. **Supplementary Figure 2.** TST induration size versus age. **Supplementary Figure 3.** IGRA with EC-fusion protein versus age. **Supplementary Figure 4.** IFN-γ response after ex vivo whole blood antigen stimulation using TST as reference standard for MTBC infection. **Supplementary Figure 5.** ROC-curve for background (i.e., unstimulated) IFN-y level for diagnosis of TB disease.
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